NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,020,556 | -52.1% | 29,654 | -52.5% | 0.03% | -52.4% |
| Q2 2023 | $6,305,059 | +111.8% | 62,482 | +93.1% | 0.06% | +96.9% |
| Q1 2023 | $2,976,407 | -31.6% | 32,352 | -32.5% | 0.03% | -17.9% |
| Q4 2022 | $4,351,022 | -99.9% | 47,961 | -66.9% | 0.04% | -33.9% |
| Q3 2022 | $5,519,514,000 | +171526.7% | 145,092 | +281.3% | 0.06% | +78.8% |
| Q2 2022 | $3,216,000 | +8.4% | 38,047 | +12.6% | 0.03% | +6.5% |
| Q1 2022 | $2,966,000 | -46.5% | 33,800 | -46.7% | 0.03% | -44.6% |
| Q4 2021 | $5,548,000 | -40.1% | 63,430 | -44.0% | 0.06% | -39.8% |
| Q3 2021 | $9,255,000 | +53.6% | 113,168 | +71.4% | 0.09% | +36.8% |
| Q2 2021 | $6,026,000 | +3.1% | 66,041 | -3.4% | 0.07% | -8.1% |
| Q1 2021 | $5,845,000 | -48.0% | 68,378 | -42.6% | 0.07% | -43.1% |
| Q4 2020 | $11,233,000 | -99.8% | 119,043 | +101.5% | 0.13% | +35.4% |
| Q3 2020 | $5,137,000,000 | – | 59,078 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |